Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: a randomized controlled trial in older adults
Journal article
Vaes, Anouk M.M., Tieland, Michael, de Regt, Margot F., Wittwer, Jonas, van Loon, Luc and de Groot, Lisette C.P.G.M.. (2018). Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: a randomized controlled trial in older adults. Clinical Nutrition. 37(3), pp. 808 - 814. https://doi.org/10.1016/j.clnu.2017.03.029
Authors | Vaes, Anouk M.M., Tieland, Michael, de Regt, Margot F., Wittwer, Jonas, van Loon, Luc and de Groot, Lisette C.P.G.M. |
---|---|
Abstract | Background & aims Oral supplementation with vitamin D is recommended for older adults to maintain a sufficient 25-hydroxyvitamin D (25(OH)D) status throughout the year. While supplementation with vitamin D2 or D3 is most common, alternative treatment regimens exist which require further investigation with respect to increasing 25(OH)D concentration. We investigated the dose–response effects of supplementation with calcifediol compared to vitamin D3 and assessed the dose which results in mean serum 25(OH)D3 concentrations between 75 and 100 nmol/L. Methods This randomized, double-blind intervention study included men and women aged ≥65 years (n = 59). Participants received either 5, 10 or 15 μg calcifediol or 20 μg vitamin D3 per day, for a period of 24 weeks. Blood samples were collected every four weeks to assess response profiles of vitamin D related metabolites; serum vitamin D3, 25(OH)D3, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and 24,25-dihydroxyvitamin D3 (24,25(OH)2D3). Further, serum calcium, plasma parathyroid hormone, and urinary calcium were evaluated. Results Supplementation with 20 μg vitamin D3 increased 25(OH)D3 concentrations towards 70 nmol/L within 16 weeks. Supplementation with 10 or 15 μg calcifediol increased 25(OH)D3 levels > 75 nmol/L in 8 and 4 weeks, respectively. Steady state was achieved from week 12 onwards with serum 25(OH)D3 levels stabilizing between 84 and 89 nmol/L in the 10 μg calcifediol group. A significant association was observed between the changes in 25(OH)D3 and 24,25(OH)2D3 (R2 = 0.83, P < 0.01), but not between 25(OH)D3 and 1,25(OH)2D3 (R2 = 0.04, P = 0.18). No cases of hypercalcemia occurred in any treatment during the study period. Conclusions Calcifediol supplementation rapidly and safely elevates serum 25(OH)D3 concentrations to improve vitamin D status in older adults. A daily dose of 10 μg calcifediol allows serum 25(OH)D3 concentrations to be maintained between 75 and 100 nmol/L. |
Year | 2018 |
Journal | Clinical Nutrition |
Journal citation | 37 (3), pp. 808 - 814 |
Publisher | Elsevier B.V. |
ISSN | 0261-5614 |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.clnu.2017.03.029 |
Scopus EID | 2-s2.0-85017514313 |
Page range | 808 - 814 |
Research Group | Mary MacKillop Institute for Health Research |
Publisher's version | File Access Level Controlled |
Place of publication | Netherlands |
Editors | N. E. P. Deutz |
https://acuresearchbank.acu.edu.au/item/89942/dose-response-effects-of-supplementation-with-calcifediol-on-serum-25-hydroxyvitamin-d-status-and-its-metabolites-a-randomized-controlled-trial-in-older-adults
Restricted files
Publisher's version
102
total views0
total downloads1
views this month0
downloads this month